Primary Synovial Sarcoma Of The Kidney: A Rare And Easily Misinterpreted Renal Entity

Bin Chang,Lixia Lu,Xiaoqun Yang,Li Xiao,Chaofu Wang

2016-01-01

Abstract:Primary synovial sarcomas of kidney are very rare, present a diagnostic dilemma. In this study, we reported clinicopathologic, immunohistochemical, and genetic characteristics of 12 cases of primary renal synovial sarcoma (SS). The ages of the 12 patients ranged from 21-52 years. Microscopically, 8 cases were monophasic type and 4 cases were biphasic type. The epithelial components of biphasic type SS were positive for AE1/AE3 (4/4) and EMA (4/4). Monophasic synovial sarcomas were focally positive for AE1/AE3 (3/8) and EMA (5/8). In all 12 cases, the spindle cell components were diffusely positive for vimentin (100.0%), BCL2 (83.3%), and CD99 (33.3%). CD10, CD34, SMA, and desmin were negative in all cases. The SS18 gene was rearranged in 10 cases. The SS18-SSX fusion gene was identified in another 2 cases. Clinical outcome data were available for 8/12 (66.7%) patients. Follow-up revealed that 5 patients (62.5%) died of the disease within 11 to 37 months after diagnosis (mean, 20.6 mo). Three patients (37.5%) were alive without evidence of disease 1 to 23 months after diagnosis (mean, 9 mo). We concluded that primary renal synovial sarcoma is a rare, aggressive tumor with poor prognosis that occurs over a wide age range but primarily in young adults and is morphologically similar to embryonal and mesenchymal neoplasms of the kidney. Adequate sampling, immunohistochemical staining, and specific fusion gene detection are essential to establish an accurate diagnosis.